AR002736A1 - Uso de ester 3-metil-5-etilico de acido 2,6-dimetil-4-(2,3-diclorofenil-1,4 -dihidropiridin-3,5-dicarboxilico (felodipina) para fabricar un medicamento ypreparacion farmaceutica para el tratamiento de la disfuncion cerebral. - Google Patents

Uso de ester 3-metil-5-etilico de acido 2,6-dimetil-4-(2,3-diclorofenil-1,4 -dihidropiridin-3,5-dicarboxilico (felodipina) para fabricar un medicamento ypreparacion farmaceutica para el tratamiento de la disfuncion cerebral.

Info

Publication number
AR002736A1
AR002736A1 ARP960102485A AR10248596A AR002736A1 AR 002736 A1 AR002736 A1 AR 002736A1 AR P960102485 A ARP960102485 A AR P960102485A AR 10248596 A AR10248596 A AR 10248596A AR 002736 A1 AR002736 A1 AR 002736A1
Authority
AR
Argentina
Prior art keywords
felodipine
dichlorophenyl
dimethyl
methyl
treatment
Prior art date
Application number
ARP960102485A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of AR002736A1 publication Critical patent/AR002736A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso del éster 3-metil-5-etílico de ácido 2,6-dimetil-4-(2,3-diclorofenil- 1,4-dihidropiridin-3,5-dicarboxílico (felodipina) o una sal farmacéutica parael tratamiento de la disfunción cerebral debido a la exposisión a solventes y una preparaciónf armacéutica que comprende el mencionado éster.
ARP960102485A 1995-05-15 1996-05-07 Uso de ester 3-metil-5-etilico de acido 2,6-dimetil-4-(2,3-diclorofenil-1,4 -dihidropiridin-3,5-dicarboxilico (felodipina) para fabricar un medicamento ypreparacion farmaceutica para el tratamiento de la disfuncion cerebral. AR002736A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501773A SE9501773D0 (sv) 1995-05-15 1995-05-15 New use

Publications (1)

Publication Number Publication Date
AR002736A1 true AR002736A1 (es) 1998-04-29

Family

ID=20398291

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102485A AR002736A1 (es) 1995-05-15 1996-05-07 Uso de ester 3-metil-5-etilico de acido 2,6-dimetil-4-(2,3-diclorofenil-1,4 -dihidropiridin-3,5-dicarboxilico (felodipina) para fabricar un medicamento ypreparacion farmaceutica para el tratamiento de la disfuncion cerebral.

Country Status (8)

Country Link
US (1) US5834497A (es)
AR (1) AR002736A1 (es)
AU (1) AU5784496A (es)
IL (1) IL118225A0 (es)
SE (1) SE9501773D0 (es)
TW (1) TW396038B (es)
WO (1) WO1996036337A1 (es)
ZA (1) ZA963484B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07501551A (ja) * 1991-12-02 1995-02-16 セプラコア，インコーポレーテッド 光学的に純粋なｓ（−）フェロジピンを用いる，高血圧，狭心症および他の疾患を治療するための方法および組成物

Also Published As

Publication number Publication date
AU5784496A (en) 1996-11-29
TW396038B (en) 2000-07-01
WO1996036337A1 (en) 1996-11-21
US5834497A (en) 1998-11-10
IL118225A0 (en) 1996-09-12
ZA963484B (en) 1996-11-15
SE9501773D0 (sv) 1995-05-15

Similar Documents

Publication Publication Date Title
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
PT87703A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um derivado de 1,4-di-hidropiridina e um intensificador do fluxo transdermico
RU94016393A (ru) Пептиды, обладающие способностью к стимулированию высвобождения гормона роста, способ получения, фармацевтическая композиция, способ лечения
PT90120A (pt) Processo para a preparacao de uma composicao farmaceutica contendo deprenil para administracao sistemica transdermica
BR8904174A (pt) Derivados de 3-aril-pirrolidin-2,4-diona(s),processo para sua preparacao,composicoes inseticidas,processos para combater insetos e para a preparacao de composicoes,aplicacao,esteres e processo para sua preparacao
PT84785B (pt) Processo para a preparacao de composicoes farmceuticas que contem omeprazole para administracao por via oral
BR9100435A (pt) Composto,composicao farmaceutica,uso,metodo de tratamento de um animal,processos para a preparacao da um composto e de uma composicao farmaceutica
RU93049997A (ru) Производные метилен-бис-фосфоновой кислоты, способ их получения, фармацевтическая композиция
DE3863904D1 (de) Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol.
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
ATE212837T1 (de) Pharmazeutische zubereitung zur behandlung akuter rhinitiden, enthaltend sympthomimeticum und pantothenol und/oder pantothensäure
DK515489D0 (da) Dispergerbar laegemiddelformulering
DK0451654T3 (da) Anvendelse af N-alkylerede 1,4-dihydropyridin-dicarboxylsyreestere som lægemidler, nye forbindelser og fremgangsmåder til deres fremstilling
ATA69888A (de) Neue substituierte benzamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese benzamide enthalten
DE59300176D1 (de) 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE68920896D1 (de) N2-(1-Carboxy-3-phenylpropyl)-L-lysinderivate und Verfahren für die Herstellung von Lysinopril mit Hilfe dieser Verbindung.
ATE135681T1 (de) Diclofenac-cholinsalz, verfahren zur herstellung und pharmazeutische zusammensetzungen, die es enthalten
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
ATE87476T1 (de) Fluessige orale formulierung.
AR002736A1 (es) Uso de ester 3-metil-5-etilico de acido 2,6-dimetil-4-(2,3-diclorofenil-1,4 -dihidropiridin-3,5-dicarboxilico (felodipina) para fabricar un medicamento ypreparacion farmaceutica para el tratamiento de la disfuncion cerebral.
ATE125538T1 (de) Thiochromanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69104608D1 (de) Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DE68928788T2 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten

Legal Events

Date Code Title Description
FA Abandonment or withdrawal